Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Sign-on Letter to FDA Requesting Withdrawal of Draft Guidance for LDTs
-
Joint Comments to CMS Concerning MolDx Program, Medicare Coverage, and Impact on MoPath Gapfill Determinations
-
ACMG Letter to Palmetto GBA Requesting Reconsideration of Cytogenetic Microarray Coverage
-
ACMG Comments to NIH about Development of the Genetic Test Registry
-
Group Letter Opposing Conscience Clause Amendments in New Jersey Assembly Bill 269 (2008)